Literature DB >> 18941401

Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient.

Anamarija Morovic1, Elaine S Jaffe, Mark Raffeld, Jeffrey A Schrager.   

Abstract

Posttransplant lymphoproliferative disorders (PTLDs) may occur as a complication of immunosuppression in patients who have received solid organ or bone marrow allografts. Most PTLDs are of B-cell lineage, whereas T-cell proliferations are rare. The majority of B-cell lesions are associated with Epstein-Barr virus infection. The occurrence of both B-cell and T-cell PTLDs in the same patient is extremely rare and only 6 cases have been previously published. We report a case of a 63-year-old man who developed 2 metachronous Epstein-Barr virus-related PTLDs beginning 10 years after heart transplantation. A polymorphic B-cell PTLD developed first that completely regressed after immunosuppressive therapy was partially withdrawn. Then, a monomorphic T-cell PTLD developed 31 months later. The patient died 17 months later owing to disease progression. We highlight the diagnostic challenge of this case that required numerous ancillary studies for lineage assessment and classification. Such studies are often needed in patients with a history of immunosuppression.

Entities:  

Mesh:

Year:  2009        PMID: 18941401      PMCID: PMC6324846          DOI: 10.1097/PAS.0b013e318181a826

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. Survey.

Authors:  Morteza Izadi; Mozhgan Fazel; Seyed Hasan Saadat; Saeed Taheri
Journal:  Hepatol Int       Date:  2011-03-30       Impact factor: 6.047

2.  Composite B-cell and T-cell lineage post-transplant lymphoproliferative disorder of the lung with unusual cutaneous manifestations of mycosis fungoides.

Authors:  Kyle C Mills; Omar P Sangüeza; Michael W Beaty; Mark Raffeld; Changlee S Pang
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

3.  Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.

Authors:  Mikiko Kobayashi; Naoko Asano; Mana Fukushima; Takayuki Honda
Journal:  Int J Hematol       Date:  2014-05-31       Impact factor: 2.490

4.  The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers?

Authors:  Mari Frances Kilner; Serena Merante; Alexandr Svec
Journal:  BMJ Case Rep       Date:  2013-12-16

5.  The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Authors:  Mohsen Navari; Maryam Etebari; Giulia De Falco; Maria R Ambrosio; Davide Gibellini; Lorenzo Leoncini; Pier Paolo Piccaluga
Journal:  Front Microbiol       Date:  2015-06-10       Impact factor: 5.640

6.  Isolated peritoneal lymphomatosis defined as post-transplant lymphoproliferative disorder after a liver transplant: A case report.

Authors:  Hong Beum Kim; Ran Hong; Yung Sub Na; Woo Young Choi; Sang Gon Park; Hee Jeong Lee
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

7.  Posttransplant lymphoproliferative disorders.

Authors:  Hazem A H Ibrahim; Kikkeri N Naresh
Journal:  Adv Hematol       Date:  2012-04-17

Review 8.  Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders.

Authors:  R Karbasi-Afshar; S Taheri
Journal:  Iran J Ped Hematol Oncol       Date:  2013-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.